Address the persistent sex-specific gaps found in guidelines, recommendations and prevention of cardiovascular disease strategies for women, and recognize diagnostic and therapeutic adherence. |
|
|
|
|
|
|
Recognize the risk factors associated with asymptomatic carotid atherosclerotic disease, and examine the evidence that supports a conservative approach to carotid revascularization in asymptomatic patients. |
|
|
|
|
|
|
Interpret and implement current guidelines on utilization of cholesterol lowering therapy to reduce the risk of heart attack and stroke. |
|
|
|
|
|
|
Examine and implement the National Lipid Association recommendations for patient-centered management of dyslipidemia. |
|
|
|
|
|
|
Cite the clinical trial evidence supporting the use of omega-3 fatty acids in cardiovascular disease prevention |
|
|
|
|
|
|
Review the randomized clinical trials currently evaluating the incremental benefit of adding omega-3 fatty acids to statin therapy in high-risk patients with elevated triglycerides. |
|
|
|
|
|
|
Examine the evidence that reveals how meditation promotes health and well-being. |
|
|
|
|
|
|
Implement strategies to effectively motivate smoking cessation behaviors in patients, and examine pharmacologic options for smoking cessation therapies. |
|
|
|
|
|
|
Implement practical treatment protocols for the management of obesity from the point of view of the practicing physician. |
|
|
|
|
|
|
Explain the role of bariatric surgery and its impact in obese individuals diagnosed with diabetes and cardiovascular diseases. |
|
|
|
|
|
|
Initiate effective patient education discussions about the minimal level of exercise needed for improved health. |
|
|
|
|
|
|
Recognize components of the optimal diet for cardiovascular health, and explain the scientific evidence behind popular weight loss diets. |
|
|
|
|
|
|
Recognize the key differences and controversies among the multitude of hypertension practice guidelines, and discuss the different rationales for variable BP goals. |
|
|
|
|
|
|
Examine the formal evidence from the FOURIER trial, and explain how targeted treatment at PCSK9 inhibition confers additional cardiovascular benefits beyond lipid-lowering treatment alone. |
|
|
|
|
|
|
Examine the current results of the CANTOS study and explain how targeting inflammation produces a direct benefit on patient outcomes. |
|
|
|
|
|
|
Examine the impact of adding empagliflozin to standard care of type 2 diabetes patients who are at high risk for cardiovascular events. |
|
|
|
|
|
|
Evaluate the implications of the absence of coronary artery calcium (CAC) in reclassifying patients from a risk stratum in which statins are recommended to one in which they are not. |
|
|
|
|
|
|
Examine statin-associated muscular adverse events, and explain how such events are typically temporal due to the initiation of statin therapy. |
|
|
|
|
|
|
Describe and recognize the usefulness of stress testing in patients with suspected coronary artery disease. |
|
|
|
|
|
|
Examine the role of coronary computed tomographic angiography as a diagnostic tool in the evaluation of patients with chest pain. |
|
|
|
|
|
|
Recognize the strong association atrial fibrillation has with other cardiovascular diseases in order to properly manage, diagnose and treat. |
|
|
|
|
|
|
Examine prevention, reversal and treatment strategies for heart failure, considering medical and surgical options. |
|
|
|
|
|
|
Assess the long-term vital prognosis of patients with abdominal aortic aneurysmal disease or peripheral artery disease to determine possible differences in survival, prognostic risk profiles and causes of death. |
|
|
|
|
|
|
Examine the primary causes of aortic stenosis, its progression and risks, and recognize the diagnostic tests and treatment options available. |
|
|
|
|
|
|